$BCLI above upper bollie $3.74
Nasdaq CM
Website
$BCLI above upper bollie $3.74
Nasdaq CM
Website
10-Q 11/14/17
80% x 96% Strong buy
Ultra low float
Shares Outstanding 18.69M
Float 16.23M
% Held by Insiders 15.19%
% Held by Institutions 9.70%
Shares Short 568.34k
Short Ratio 7.59
Short % of Float 3.50%
Shares Short (prior month) 3555.38k
Last ten trades
Stock technical analysis
News
and filings
Brainstorm Cell Therapeutics Inc., a biotechnology company, develops adult stem cell therapies for neurodegenerative disorders. It holds rights to develop and commercialize its NurOwn technology through a licensing agreement with Ramot of Tel Aviv University Ltd. The companys NurOwn technology is based on a novel differentiation protocol, which induces differentiation of the bone marrow-derived mesenchymal stem cells into neuron-supporting cells and secreting cells that release neurotrophic factors, including glial-derived neurotrophic factor, brain-derived neurotrophic factor, vascular endothelial growth factor, and hepatocyte growth factor for the growth, survival, and differentiation of developing neurons. The company was formerly known as Golden Hand Resources Inc. and changed its name to Brainstorm Cell Therapeutics Inc. in November 2004 to reflect its new line of business in the development of novel cell therapies for neurodegenerative diseases. Brainstorm Cell Therapeutics Inc. was founded in 2000 and is headquartered in Hackensack, New Jersey.
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP
Scroll down for more posts ▼
Top 10 Most Recent News Articles
HITRUST i1 Certification: The Gold Standard in Security For a world increasingly reliant on digital infrastructure, cybersecurity certification is no longer just a badge of honor; it's a cornerstone of trust. Dentistry.One nailed this down by bagging that coveted HITRUST i1 certification. When folks talk about securing data, HITRUST might as well be speaking gospel. We're...
Continue Reading
Breaking New Ground in Neuromodulation Medical tech's on a roll, and Cala Health just hopped on the fast track with their latest launch—the Cala kIQ Plus System. This bad boy is aiming to offer relief for those grappling with hand tremors, thanks to its FDA clearance and a host of new features. It's the first of its kind, combining multiple therapy modes with an...
Continue Reading
A Missed Opportunity for Community Banks It's a classic tale: community banks sleepwalking while big players snatch up low-hanging fruit right in their own backyards. According to the latest report by Cornerstone Advisors, commissioned by Teslar Software, these banks are essentially leaving $106 billion on the table when it comes to consumer lending. That's not just chump...
Continue Reading
NYSE Texas: Carving a Niche The notion of 'Y'all Street' might seem like a gimmick, but NYSE Texas is pushing a serious agenda with its newly released white paper, 'NYSE Texas and the Reshaping of U.S. Capital Markets.' This is no small feat. Texas is already housing 235 NYSE-listed companies, boasting a colossal combined worth of $4.8 trillion. With 130 of these firms...
Continue Reading
Adams' Provocative Debut Asks Timeless Questions Sometimes life throws a philosophical curveball, and that's exactly what John C. Adams has done with his debut novel, The Third Phase. This isn't your average political yarn—it's an intricate tapestry intertwining political intrigue, deep spiritual inquiry, and hearty doses of classic philosophy. A Whirlwind Journey...
Continue Reading
Bringing Capital and Content Under One Roof There's something in the air as Itibari-Waynne & Partners (IWP) team up with the VYRE Network to crank out a fresh slate of content for VYRE Business News Global (VBNGtv). This partnership ain't just another splash in the buzzy world of digital media; it's like merging Wall Street with Hollywood. IWP, prepping to go full...
Continue Reading
Truss Financial Group's Bold Move Against Closing Delays In real estate, time is money. Even the most casual market observer could tell you delays can slice through a deal like a hot knife through butter. That's the headache home equity borrowers face, blindsided by closing delays that sneak up on them without warning. An Industry Bottleneck Finally Addressed Enter Truss...
Continue Reading
Change of Guard in Cardiac Health at Karoo Here's a move that might shake things up in the healthtech sector: Karoo Health just snagged Angela "Angie" Breton as their new Chief Commercial Officer. It's like putting a seasoned captain at the helm right before setting sail on uncharted waters. Breton's not just any captain—she's got a hefty 25 years of experience...
Continue Reading
A Global Stage for Pet Nutrition Science The folks over at the Purina Institute are back in the spotlight as they gear up to throw their weight behind the 51st World Small Animal Veterinary Association (WSAVA) Congress in Warsaw, Poland. Set for October 13-15, 2026, this isn’t just another event—they're bringing some serious clout with their 'Food for Thought'...
Continue Reading
Peering Into CNG's Latest Innovation Charter Next Generation (CNG) just threw down a hefty gauntlet with its launch of next-gen machine-direction-oriented polyethylene (MDO-PE) solutions. They're pushing the envelope on what recycle-ready packaging can do, folks. Let's not mince words—other players in the field better have their game faces on. This ain't just another...
Continue Reading
Top 5 Most Recently Viewed Articles
Understanding Albion's Upcoming Capital Raises Albion Enterprise VCT PLC, along with Albion Technology & General VCT PLC and Albion Crown VCT PLC, are gearing up for an exciting opportunity for investors. They have announced plans, pending necessary regulatory approvals, to launch a series of prospectus top-up offers aimed at expanding their ordinary shares in the...
Continue Reading
Progressive Corporation Declares Quarterly Dividend On March 7, 2025, the Board of Directors of The Progressive Corporation (NYSE: PGR) made a significant announcement regarding its commitment to shareholders by declaring a quarterly dividend of $0.10 per common share. This dividend is set to be payable on April 11, 2025, to those shareholders who are on record at the...
Continue Reading
Marine Cabirou Triumphs in UCI Downhill Mountain Bike World Cup 28-year-old Marine Cabirou from France emerged victorious in the Elite Women’s division during the final race of the 2025 UCI Downhill Mountain Bike World Cup held at Mont-Sainte-Anne. Her impressive performance not only marks her second win of the year but also serves as a significant comeback after...
Continue Reading
Azome Therapeutics Partners with NCATS for Novel Research Azome Therapeutics, an innovative drug development company, has recently announced a partnership aimed at investigating a groundbreaking therapy targeting Bronchopulmonary Dysplasia (BPD). This collaboration with the National Center for Advancing Translational Sciences (NCATS) focuses on the preclinical development...
Continue Reading
Teladoc Health Prepares for Third Quarter Financial Results Teladoc Health Inc. (NYSE: TDOC), celebrated as a pioneer in virtual care, is gearing up to announce its financial results for the third quarter of 2025. Investors and the public are eagerly anticipating the release, which is set to take place after the market closes on October 29, 2025. This pivotal moment for...
Continue Reading